DUXAP10 (Yao et al., 2018) was upregulated in chronic myelogenous leukemia (CML) THP-1, KG-1, and K562 cells, and its expression level was observed to gradually increase in response to clinical upstaging of CML (chronic phase, acceleration phase, and blast phase). This evidence concerns the gene DUXAP10 and chronic myelogenous leukemia, BCR-ABL1 positive.